T

Tenax Therapeutics
D

TENX

4.63000
USD
0.04
(0.87%)
مغلق
حجم التداول
345
الربح لكل سهم
0
العائد الربحي
0
P/E
-0
حجم السوق
15,783,235
أصول ذات صلة
    C
    CTR
    -0.170
    (-0.42%)
    40.090 USD
    MCO
    3.99
    (0.87%)
    460.83 USD
    P
    PAY
    -0.640
    (-3.03%)
    20.510 USD
    P
    PPT
    0.04000
    (1.10%)
    3.67000 USD
الأخبار المقالات

العنوان: Tenax Therapeutics

القطاع: Healthcare
الصناعة: Biotechnology
Tenax Therapeutics Inc is a specialty pharmaceutical company focused on identifying, developing, and commercializing products that address cardiovascular and pulmonary diseases with high unmet medical needs. The company owns North Americanrights to develop and commercialize levosimendan and has released topline data regarding the Phase 2 clinical trial for the use of levosimendan in the treatment of pulmonary hypertension associated with Heart Failure and preserved EjectionFraction.